Corestreet Logo

Fate Therapeutics Inc (FATE) Insider Trading

Total insider buys:
  • $140,338,122.89
Total insider sells:
  • $85,937,046.68
Most recent insider trade:
  • Aug. 6, 2024
Most active insider trader:
  • J Scott Wolchko
Trader NameDateTitleAmountPriceTypeTotal Value
Aug. 6, 2024Director633$4.23Sell$2,677.59
Jan. 29, 2024CFO1,849$5.00Sell$9,245.00
Jan. 9, 2024Insider11,271$4.38Sell$49,366.98
Jan. 9, 2024CEO14,391$4.37Sell$62,888.67
Jan. 9, 2024CFO7,028$4.37Sell$30,712.36
Jan. 9, 2024General Counsel10,874$4.37Sell$47,519.38
Dec. 26, 2023Director44,630$3.72Buy$166,023.60
Aug. 18, 2023CFO4,718$2.80Sell$13,210.40
Aug. 4, 2023Director632$3.71Sell$2,344.72
July 5, 2023CFO5,182$4.83Sell$25,029.06
July 5, 2023Insider3,854$4.87Sell$18,768.98
June 14, 2023Director3,460$5.58Sell$19,306.80
April 20, 2023Director20,000$5.99Buy$119,800.00
April 18, 2023Insider2,532$6.57Sell$16,635.24
April 14, 2023Director25,700$6.00Buy$154,200.00
Jan. 13, 2023Director36,631$5.43Buy$198,906.33
Jan. 11, 2023Director88,048$5.67Buy$499,232.16
Jan. 10, 2023CFO7,331$5.24Sell$38,414.44
Jan. 10, 2023General Counsel11,553$5.24Sell$60,537.72
Jan. 10, 2023Insider10,917$5.24Sell$57,205.08
Jan. 10, 2023CEO45,907$5.24Sell$240,552.68
Aug. 18, 2022CFO5,135$29.81Sell$153,074.35
July 21, 2022CEO30,000$32.88Sell$986,400.00
July 7, 2022Chief R&D Officer17,158$30.23Sell$518,686.34
July 7, 2022Insider17,158$30.23Sell$518,686.34
July 5, 2022Insider3,719$24.61Sell$91,524.59
June 7, 2022Director841$21.89Sell$18,409.49
June 3, 2022Director1,364$22.79Sell$31,085.56
April 21, 2022CEO30,000$35.00Sell$1,050,000.00
April 19, 2022Insider4,062$35.37Sell$143,672.94
April 1, 2022General Counsel25,000$38.85Sell$971,250.00
March 10, 2022Director31,562$35.02Sell$1,105,301.24
Jan. 20, 2022CEO30,000$40.21Sell$1,206,300.00
Jan. 11, 2022VP3,965$48.51Sell$192,342.15
Jan. 11, 2022CFO1,770$48.45Sell$85,756.50
Jan. 10, 2022Insider5,596$46.38Sell$259,542.48
Jan. 10, 2022CEO34,156$46.86Sell$1,600,550.16
Jan. 10, 2022General Counsel7,738$46.43Sell$359,275.34
Dec. 20, 2021CFO15,977$60.00Sell$958,620.00
Dec. 13, 2021Insider25,000$47.66Sell$1,191,500.00
Dec. 10, 2021VP7,500$51.46Sell$385,950.00
Nov. 18, 2021CEO20,000$54.27Sell$1,085,400.00
Oct. 21, 2021CEO30,000$60.22Sell$1,806,600.00
Oct. 1, 2021General Counsel50,000$58.83Sell$2,941,500.00
Sept. 28, 2021CFO19,460$62.53Sell$1,216,833.80
Aug. 19, 2021CEO20,000$88.01Sell$1,760,200.00
Aug. 19, 2021CFO3,474$88.26Sell$306,615.24
July 22, 2021CEO30,000$86.05Sell$2,581,500.00
June 14, 2021Insider25,000$89.32Sell$2,233,000.00
April 23, 2021CEO30,000$85.24Sell$2,557,200.00
First«1 of 3»Last

  • Insiders are both buying and selling Fate Therapeutics Inc stock.

  • The insider traders at Fate Therapeutics Inc are: J Scott Wolchko, Cindy Tahl, Amir Nashat, Bahram Valamehr, Edward J Dulac III, Redmile Group, Llc, Daniel D Shoemaker, Yu-Waye Chu, John Mendlein, Peter D Flynn, Yuan Xu, Chris Storgard, Brian T Powl, Shefali Agarwal, Valamehr Bahram, Venture Fund Vi Lp Arch, William H Rastetter, Mark Plavsic, and Christian Weyer

  • The most active insider trader at Fate Therapeutics Inc is J Scott Wolchko with 22 trades.

  • J Scott Wolchko has sold the most Fate Therapeutics Inc stock with a total value of $38,805,080.89.

  • Redmile Group, Llc has bought the most Fate Therapeutics Inc stock with a total value of $133,606,012.88.

  • The most recent insider trade for Fate Therapeutics Inc was on Aug. 6, 2024.

  • The single biggest insider buy for Fate Therapeutics Inc was from Redmile Group, Llc with a total value of $50,000,004.00 on Sept. 25, 2018.

  • The single biggest insider sell for Fate Therapeutics Inc was from J Scott Wolchko with a total value of $8,074,116.31 on Jan. 11, 2021.